GL1X · GenesisL1 explorer

MolNFT v1 · #75906 · protein

Clinically useful alkyl amine renin inhibitors

3Q4B: “Clinically useful alkyl amine renin inhibitors”. X-ray diffraction, 3 ligands (RX5, NAG, CL), 1 pocket (best druggability 0.87). MolNFT v1 #75906 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
3Q4B
Type
protein
Length
674 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Renin
EC
3.4.23.15
UniProt
P00797
Ligands
RX5, NAG, CL
Pockets
1 · best druggability 0.87

Structure

x-ray diffraction · 1 distinct chain · 14% helix, 44% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BRenin (EC 3.4.23.15)protein33714% helix, 44% strandP00797

Ligands and binding sites

  • RX5 · methyl (2-{(R)-(3-chlorophenyl)[(3R)-1-({(2S)-2-(methylamino)-3-[(3R)-tetrahydro-2H-pyran-3-yl]propyl}carbamoyl)piperidin-3-yl] methoxy}ethyl)carbamate · ligand · 2 copies · chains A, B
  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · chains A
  • CL · Chloride ion · ion · 6 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
111430.870.88114RX5, CL

Interfaces

1 interface between chains.

  • A–B · 862 Ų buried · 0 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 6 disulfide, 1 glycan (disulfide, N-glycosylation).

Compared structures

  • 3Q4B · Clinically Useful Alkyl Amine Renin Inhibitors · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.